4H-FURO[3,2-C]PYRAN-2(6H)-ONE, 4-HYDROXY-, 99%, 50mg

Fmoc-N-methyl-D-norvaline, 100mg

2-Methylheptanoic acid, 97.0%, 100g

2-Phenylindole-3-carboxaldehyde>98.0%(GC)1g

(prop-2-en-1-yl)({[3-(trifluoromethyl)phenyl]methyl})amine hydrochloride, 95.0%, 10g

3-(1,3,4-Oxadiazol-2-yl)benzoic acid, 95%, 1g

2-Chloro-3-pyridylcarboxaldehyde, 97.0%, 25g

2,5-Dibromo-3-nitropyridine, 95.0%, 1g

3-(2,4-Difluorophenyl)-3-oxo-propionic acid ethyl ester, 95.0%, 2g

Membrane de dialyse Spectra/Por® 1 à 4 Spectra/Por® 2 - MWCO 12 000 à 14 000, 105 mm, 1 Pièce(s)

3-Amino-1-(diphenylmethyl)azetidine>98.0%(GC)5g

4-chloropyrazolo[1,5-a]pyrazine, 95.0%, 2.5g

Methyl 4-(hydroxy(phenyl)methyl)benzoate, 95.0%, 5g